跳至主要内容
临床试验/NCT03531879
NCT03531879已完成不适用

ARROW: identificAtion of postpRandial biomaRkers tOWards Cardiovascular Prevention

Société des Produits Nestlé (SPN)1 个研究点 分布在 1 个国家目标入组 116 人开始时间: 2018年5月23日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
116
试验地点
1
主要终点
To compare the kinetics of postprandial biomarkers between two groups of healthy subjects with and without subclinical atherosclerosis

研究概览

简要总结

The purpose of this study is to better understand the association between the postprandial biomarker responses after a food challenge with the development of cardiovascular diseases in healthy subjects

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Cross Sectional

入排标准

年龄范围
40 Years 至 54 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Willing and able to sign written informed consent in English or Chinese prior to trial entry
  • 40-54 years old
  • Both male and female subjects
  • Chinese ethnic group (having both grandparents Chinese)
  • Low Framingham risk of CHD (<10%)
  • Apparently healthy (i.e. no chronic or ongoing acute disease), based on investigator's clinical judgement

排除标准

  • Food allergy to any of the constituents of the meal challenge (milk proteins, lactose, soy).
  • Subjects not willing or not able to comply with scheduled visits and the requirements of the study protocol.
  • Contraindication to MRI
  • Pregnant or lactating women based on investigator's clinical judgement.
  • Morbid obesity (BMI ≥ 40 kg/m2).
  • Previous myocardial infarction (MI). This will include ST-elevation MI (STEMI) and non-ST-elevation MI (NSTEMI).
  • Known coronary artery disease - prior coronary revascularization.
  • Known documented peripheral arterial disease.
  • Previous stroke (defined as new focal neurological deficit persisting more than 24hours).
  • Use of anti-hypertensive agents.
  • Prior history of cancer (excludes pre-cancerous lesions).
  • Life expectancy less than 1 year.
  • Known definite diabetes mellitus or on treatment for diabetes mellitus.
  • Known autoimmune disease or genetic disease.
  • Known endocrine and metabolic diseases, even on treatment, including hyperlipidemia.
  • Psychiatric illness.
  • Asthma or chronic lung disease requiring long term medications or oxygen.
  • Chronic infective disease, including tuberculosis, hepatitis B and C; and HIV.
  • Currently participating or having participated in another clinical trial within 4 weeks prior to trial start (except for Biobank Study and SingHeart).

结局指标

主要结局

To compare the kinetics of postprandial biomarkers between two groups of healthy subjects with and without subclinical atherosclerosis

时间窗: Within 28 days from enrollment

次要结局

未报告次要终点

研究者

发起方
Société des Produits Nestlé (SPN)
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验